Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely thyroid hormone 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing precisely thyroid hormone 180 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing precisely flutamide 125 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Finasteride 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Thiamazole 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Thiamazole 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Tamoxifen citrate 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
levothyroxinnatrium 38 µg + liothyroninnatrium 9 µg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing thyroxine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing propylthiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon alfa 1200 IE pulver og solvens til injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Follitropin recombinant 75iu/luteinizing hormone 75iu/sodium chloride 9% wv powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
fulvestrant 50 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
fulvestrant 50 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 2,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing dutasteride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing precisely dutasteride 500 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Thyroid hormone measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
2 |
Brain natriuretic peptide measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
24 hour urine metadrenaline output (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
24 hour urine normetadrenaline output (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Urine normetadrenaline level (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Urine androstenedione level (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
24 hour urine androstenedione output (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
24 hour urine homovanillylmandelic acid output (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Urine metadrenaline level (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing lutropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Lutropin alfa 75iu injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
humant luteiniserende hormon-produkt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
rekombinant humant luteiniserende hormon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Renin and aldosterone (procedure) |
Component |
True |
Hormone |
Inferred relationship |
Some |
1 |
Product containing drospirenone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Ethinylestradiol+drospirenone 30micrograms/3mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med androgen OG/ELLER anabol congener |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Chlorotrianisene preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing iothiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Poisoning by pituitary hormone |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
antityroidt middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med desoxycorticosteronderivat |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med binyrebarksteroid |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing metyrapone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
naturligt hormon-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med natriumlevothyroxin |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
hypofysiotropt hormonpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
kontraceptivum til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing thyroid hormone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Estrogen receptor agonist-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
clomifencitrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing methylthiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing androgen receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Poisoning by phenformin |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med hormon OG/ELLER syntetisk substitutionspræparat |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
non-steroidt østrogen-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing tamoxifen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing dextrothyroxine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
kombinationspræparat med østrogen og progestin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Poisoning by vasopressin |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
steroidt østrogen-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
forgiftning med thyroideahormon OG/ELLER thyroideaderivat |
Causative agent |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing norgestomet (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing altrenogest (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
syntetisk antihormon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
syntetisk antiandrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing cyproterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing flutamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
syntetisk antiøstrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing toremifene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
syntetisk antigonadotropin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing gestrinone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing paroxypropione (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Exogenous hormones |
Is a |
True |
Hormone |
Inferred relationship |
Some |
|
andet hormon end kønshormon |
Is a |
False |
Hormone |
Inferred relationship |
Some |
|
Fetoplacental hormone |
Is a |
True |
Hormone |
Inferred relationship |
Some |
|
Hypofyse- eller binyrehormon |
Is a |
False |
Hormone |
Inferred relationship |
Some |
|
måling af placentalt lactogen |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Serum total T3 level (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Plasma insulin measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Natriuretic factor (substance) |
Is a |
False |
Hormone |
Inferred relationship |
Some |
|
Implantation of subcutaneous contraceptive (procedure) |
Direct substance |
False |
Hormone |
Inferred relationship |
Some |
2 |
indsættelse af Norplant |
Direct substance |
False |
Hormone |
Inferred relationship |
Some |
1 |
Implantation of subcutaneous contraceptive in arm |
Direct substance |
False |
Hormone |
Inferred relationship |
Some |
3 |
Urine catecholamine test |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Dopamine measurement, blood |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Dopamine measurement |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Urine free catecholamine measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Serum dopamine measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Plasma catecholamine measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Pancreastatin level (procedure) |
Component |
True |
Hormone |
Inferred relationship |
Some |
1 |
Blood catecholamine measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Some |
|
Hormone replacement therapy |
Direct substance |
True |
Hormone |
Inferred relationship |
Some |
1 |
Hormone implant replacement therapy |
Direct substance |
False |
Hormone |
Inferred relationship |
Some |
1 |
Hormone replacement therapy ongoing treatment (procedure) |
Direct substance |
True |
Hormone |
Inferred relationship |
Some |
1 |
Calcium regulating hormone (substance) |
Is a |
True |
Hormone |
Inferred relationship |
Some |
|
Product containing cyclofenil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
Product containing androgen receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
kombineret oralt præventionsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
ethinylestradiol + levonorgestrel flerfase p-pille |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
kønshormonprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
P-pille, flerfasepræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|
fertilitetsfremmende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Some |
|